Rahul Singhvi
Fortune : 311 876 $ au 30/06/2026
Fortune : 311 876 $ au 30/06/2026
Rahul Singhvi founded National Resilience, Inc. in 2020, where he worked as CO-Chief Executive Officer & Director from 2020 to 2025.
Dr. Singhvi also founded Axella Solutions LLC, where he is working as Managing Partner, Resilience Biotechnologies, Inc., where he is working as Chief Executive Officer, and Axella Biosciences, Inc., where he is working as President, Secretary, Treasurer & Director.
Dr. Singhvi also currently works at Swiftscale Biologics, Inc., as Chief Executive Officer, Codexis, Inc., as Independent Director from 2022, Stratus Therapeutics, Inc., as Director, Kairos Pharma Ltd., as Independent Director from 2024, Tag1 Consulting, Inc., as Director from 2024, and Keck Graduate Institute of Applied Life Sciences, as Trustee.
Dr. Singhvi also formerly worked at Novavax, Inc., as President & Chief Executive Officer from 2005 to 2011, Merck & Co., Inc., as Director-Manufacturing Division from 1999 to 2004, ImmunoCellular Therapeutics Ltd., as Lead Independent Director from 2011 to 2018, NewGen BioPharma Corp., as Director, Univercells SA, as Director, Valor Biotherapeutics LLC, as Director, Magnum Hunter Resources, Inc., as Chief Operating Officer, Bill, Hillary & Chelsea Clinton Foundation, as Member, Ring Therapeutics, Inc., as President from 2019 to 2020, Caliber Biotherapeutics LLC, as Managing Partner, Takeda Vaccines, Inc., as Chief Operating Officer, Flagship Pioneering, LLC, as Operating Partner from 2019 to 2020, Takeda Pharmaceutical Co., Ltd., as Chief Operating Officer from 2013 to 2019, and Flagship Pioneering, LLC, as Partner.
Dr. Singhvi received his graduate degree and doctorate degree from Massachusetts Institute of Technology, undergraduate degree from Indian Institute of Technology Kanpur, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CODEXIS, INC. 0,15% | 17/06/2026 | 137 052 ( 0,15% ) | 309 738 $ | 30/06/2026 |
KAIROS PHARMA, LTD. 0,03% | 31/03/2026 | 5 569 ( 0,03% ) | 2 138 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CODEXIS, INC. | Directeur/Membre du Conseil | 28/09/2022 |
| KAIROS PHARMA, LTD. | Directeur/Membre du Conseil | 10/12/2024 |
Tag1 Consulting, Inc.
Tag1 Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Directeur/Membre du Conseil | 01/10/2024 |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Swiftscale Biologics, Inc.
Swiftscale Biologics, Inc. BiotechnologyHealth Technology Develops protein synthesis technologies | Directeur Général | - |
Resilience Biotechnologies, Inc.
Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Directeur Général | - |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Directeur/Membre du Conseil | - |
Axella Solutions LLC | Fondateur | - |
| Sociétés | Poste | Fin |
|---|---|---|
National Resilience, Inc.
National Resilience, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces medicines | Fondateur | 01/01/2025 |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 25 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Magnum Hunter Resources, Inc.
Magnum Hunter Resources, Inc. Integrated OilEnergy Minerals Provides oil exploration and drilling services | Energy Minerals |
Codexis, Inc.
Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
ImmunoCellular Therapeutics Ltd.
ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology Kanpur
Indian Institute of Technology Kanpur Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bill, Hillary & Chelsea Clinton Foundation
Bill, Hillary & Chelsea Clinton Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides education, leadership development and women empowerment services | Commercial Services |
NewGen BioPharma Corp. /Old/
NewGen BioPharma Corp. /Old/ Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
Caliber Biotherapeutics LLC
Caliber Biotherapeutics LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes protein-based therapeutics and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axella Solutions LLC | |
Univercells SA
Univercells SA Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences company which develops biologics | Commercial Services |
Takeda Vaccines, Inc.
Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Commercial Services |
Valor Biotherapeutics LLC | |
Swiftscale Biologics, Inc.
Swiftscale Biologics, Inc. BiotechnologyHealth Technology Develops protein synthesis technologies | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Tag1 Consulting, Inc.
Tag1 Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
National Resilience, Inc.
National Resilience, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces medicines | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
Resilience Biotechnologies, Inc.
Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Kairos Pharma Ltd.
Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national